@skylinedrifter
NIH researchers discovered that a new form of personalized cancer immunotherapy dramatically improved the treatment’s effectiveness in patients with metastatic gastrointestinal cancers, offering hope that this therapy could be used to treat a variety of solid tumors. https://t.co/hT0V43NowV